
Melanoma vaccine trial reveals promising results
In the heart of Rochester, a beacon of hope shines brightly as researchers unveil a groundbreaking personalized mRNA vaccine for melanoma. This innovative development, born from the collaboration of pharmaceutical giants Merck and Moderna, has ignited a spark of optimism among patients and families...

